Saberi E, Kordi-Tamandani
DM, Jamali S, Rigi-Ladiz
MA, Augend A. Analysis of methylation and mRNA expression status of FADD
and FAS genes in patients with
oral squamous cell
carcinoma. Med Oral Patol Oral Cir Bucal.
2014 Nov 1;19 (6):e562-8.
doi:10.4317/medoral.19805
http://dx.doi.org/doi:10.4317/medoral.19805
|
1. Parkin
DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. |
|
|
|
|
|
2. Argiris
A, Karamouzis MV, Raben
D, Ferris RL. Head and neck cancer.
Lancet. 2008;371:1695-709. |
|
|
|
|
|
3. Goot-Heah
K, Kwai-Lin T, Froemming
GR, Abraham MT, Nik Mohd Rosdy NM, Zain RB. Human papilloma virus 18 detection in oral squamous cell carcinoma and potentially malignant lesions using saliva samples. Asian Pac J Cancer
Prev. 2012;13:6109-13. |
|
|
|
|
|
4. Rigi-Ladiz
MA, Kordi-Tamandani DM, Torkamanzehi
A. Analysis of hypermethylation
and expression profiles
of APC and ATM genes in patients with oral squamous cell carcinoma. Clin Epigenetics. 2011;3:6. |
|
|
|
|
|
5. Hasegawa
M, Nelson HH, Peters E, Ringstrom
E, Posner M, Kelsey KT. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene. 2002;21:4231-6. |
|
|
|
|
|
6. Shaw R. The
epigenetics of oral cancer.
Int J Oral Maxillofac Surg. 2006;35:101-8. |
|
|
|
|
|
7. Shaw RJ, Hall GL, Woolgar JA, Lowe D, Rogers SN, Field JK, et al. Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br J
Oral Maxillofac Surg.
2007;45:617-22. |
|
|
|
|
|
8. Supić
G, Kozomara R, Branković-Magić
M, Jović N, Magić
Z. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Oral Oncol. 2009;45:1051-7. |
|
|
|
|
|
9. Supic
G, Jovic N, Kozomara R, Zeljic K, Magic Z. Interaction between the MTHFR C677T polymorphism
and alcohol--impact on
oral cancer risk and multiple DNA methylation of
tumor-related genes. J Dent
Res. 2011;90:65-70. |
|
|
|
|
|
10. Gopisetty
G, Ramachandran K, Singal
R. DNA methylation and apoptosis. Mol Immunol. 2006;43:1729-40. |
|
|
|
|
|
11. Li C, Wang L, Su J, Zhang R,
Fu L, Zhou Y. mRNA expression and hypermethylation
of tumor suppressor genes apoptosis protease activating factor-1
and death-associated protein
kinase in oral squamous cell carcinoma. Oncol Lett. 2013;6:280-6. |
|
|
|
|
|
12. Zacks
DN, Zheng QD, Han Y, Bakhru
R, Miller JW. FAS-mediated apoptosis and its relation to intrinsic pathway activation in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci. 2004;45:4563-9. |
|
|
|
|
|
13. Yan
MD, Hong CC, Lai GM, Cheng
AL, Lin YW, Chuang SE. Identification and characterization
of a novel gene Saf transcribed
from the opposite strand of Fas. Hum Mol Genet. 2005;14:1465-74. |
|
|
|
|
|
14. Maurillo L, Del Poeta G, Venditti A, Buccisano F, Battaglia A, Santinelli S, et
al. Quantitative analysis
of Fas and bcl-2 expression in hematopoietic
precursors. Haematologica.
2001;86:237-43. |
|
|
|
|
|
15. Nagata
S. Apoptosis by death
factor. Cell. 1997;88:355-65. |
|
|
|
|
|
16. Danial
NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205-19. |
|
|
|
|
|
17. Asuthkar
S, Velpula KK, Chetty C, Gorantla B, Rao JS. Epigenetic regulation of
miRNA-211 by MMP-9 governs
glioma cell apoptosis, chemosensitivity
and radiosensitivity. Oncotarget.
2012;3:1439-54. |
|
|
|
|
|
18. Prapinjumrune
C, Morita K, Kuribayashi Y, Hanabata
Y, Shi Q, Nakajima Y, et
al. DNA amplification and expression
of FADD in oral squamous cell
carcinoma. J Oral Pathol Med.
2010;39:525-32. |
|
|
|
|
|
19. Guler
N, Uckan S, Celik I, Oznurlu Y, Uckan D. Expression of Fas and Fas-ligand
and analysis of argyrophilic
nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and
apoptosis. Int J Oral Maxillofac
Surg. 2005;34:900-6. |
|
|
|
|
|
20. Kordi-Tamandani
DM, Ladies MA, Hashemi M, Moazeni-Roodi
AK, Krishna S, Torkamanzehi A. Analysis
of p15INK4b and p16INK4a gene methylation in patients with oral squamous cell carcinoma. Biochem Genet. 2012;50:448-53. |
|
|
|
|
|
21. Conerly
M, Grady WM. Insights into
the role of DNA methylation
in disease through the use of mouse models. Dis Model Mech.
2010;3:290-7. |
|
|
|
|
|
22. Mitsiades
CS, Anderson KC. Epigenetic modulation
in hematologic malignancies:
challenges and progress. J
Natl Compr Canc Netw. 2009;7 Suppl 8:S1-12. |
|
|
|
|
|
23. Lopez-Serra
L, Esteller M. Proteins that bind methylated
DNA and human cancer: reading the wrong
words. Br J Cancer. 2008;98:1881-5. |
|
|
|
|
|
24. Li W, Xia
D, Wang Y, Li Y, Xue Y, Wu
X, et al. Relationship between
aberrant methylation of
FAS promoter and biological
beha-vior of bladder urothelial carcinoma. J Huazhong
Univ Sci Technolog Med Sci. 2011;31:794-8. |
|
|
|
|
|
25. Wu
J, Wood GS. Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein,
and enhancement of sensitivity
to apoptosis in cutaneous
T-cell lymphoma. Arch Dermatol. 2011;147: 443-9. |
|
|
|
|
|
26. Chaopatchayakul
P, Jearanaikoon P, Yuenyao
P, Limpaiboon T. Aberrant
DNA methylation of apoptotic
signaling genes in patients
responsive and nonresponsive
to therapy for cervical carcinoma. Am J Obstet
Gynecol. 2010;202:281.e1-9. |
|
|
|
|
|
27. Petak
I, Danam RP, Tillman DM, Vernes R, Howell SR, Berczi L, et al. Hypermethylation
of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma. Cell
Death Differ.2003;10:211-7. |
|
|
|
|
|
28. Hopkins-Donaldson
S, Ziegler A, Kurtz S, Bigosch C, Kandioler D, Ludwig C,et al. Silencing
of death receptor and caspase-8 expression
in small cell lung carcinoma cell lines and tumors by DNA methylation.Cell Death Differ. 2003;10:356-64. |
|
|
|
|
|
29. Alenzi
FQ. Links between apoptosis, proliferation
and the cell cycle. Br J Biomed Sci. 2004;61:99-102. |
|
|
|
|
|
30. Ohno
S, Tachibana M, Shibakita
M, Dhar DK, Yoshimura H, Kinugasa S, et al. Prognostic significance of Fas and Fas ligand
system-associated apoptosis in gastric
cancer. Ann Surg Oncol. 2000;7:750-7. |
|
|
|
|
|
31. Gratas C, Tohma
Y, Barnas C, Taniere P,
Hainaut P, Ohgaki H. Up-regulation
of Fas (APO-1/CD95) ligand and down-regulation
of Fas expression in human
esophageal cancer. Cancer Res. 1998;58:2057-62. |
|
|
|
|
|
32. Nagao
M, Nakajima Y, Hisanaga
M, Kayagaki N, Kanehiro
H, Aomatsu Y, et al. The alteration of Fas receptor and ligand
system in hepatocellular
carcinomas: how do hepatoma
cells escape from the host immune surveillance in vivo? Hepatology. 1999;30:413-21. |
|
|
|
|
|
33. Muraki
Y, Tateishi A, Seta C, Fukuda
J, Haneji T, Oya R, et
al. Fas antigen expression
and outcome of oral squamous
cell carcinoma. Int J
Oral Maxillofac Surg.
2000;29:360-5. |
|
|
|
|
|
34. Chen
Q, Samaranayake LP, Zhen
X, Luo G, Nie M, Li B.
Up-regulation of Fas ligand
and down-regulation of Fas expression
in oral carcinogenesis. Oral Oncol.1999;35:548-53. |
|
|
|
|
|
35. Shin
MS, Kim HS, Lee SH, Lee JW, Song YH, Kim YS, et al.Alterations of Fas-pathway
genes associated with
nodal metastasis in non-small
cell lung cancer. Oncogene. 2002;21:4129-36. |
|
|
|
|
|
36. Gibcus
JH, Menkema L, Mastik MF,
Hermsen MA, de Bock GH, van Velthuysen
ML,et al. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the
11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res.2007;13:6257-66. |
|
|
|
|
|
37. Lo Muzio
L, Santarelli A, Emanuelli
M, Pierella F, Sartini D,
Staibano S,et
al. Genetic analysis of
oral squamous cell
carcinoma by cDNA microarrays focused apoptotic pathway. Int J Immunopathol Pharmacol. 2006;19:675-82. |
|
|
|
|
|
38. Lo Muzio
L, Sartini D, Santarelli
A, Rocchetti R, Morganti
S, Pozzi V, et al. Expression
and prognostic significance
of apoptotic genes in oral squamous
cell carcinoma. Mol Carcinog.
2014;53:264-71. |
|
|
|
|